Fig. 2

CVE prevalence ratios among MLSP patients with SLE by age-group, sex, and race and ethnicity. Figure 2 footnote: Adjusted prevalence ratios comparing MLSP data from 2007 among Manhattan Residents to NHANES data from 2009–2010. Age-standardized prevalence ratios (ASPR) were calculated based on prevalence of heart attack or stroke among (20–49 and 50+)